TONGRENTANGCM (03613) has been issued a registration certificate for traditional Chinese medicine.

TONGRENTANGCM (03613) announced that the company recently received the "Certificate of Registration of Traditional Chinese Medicine" issued by the Hong Kong Chinese Medicine Management Committee, allowing the sale of "San Zi Yang Qin Granules [Beijing Tongrentang]" in the Hong Kong Special Administrative Region of the Peoples Republic of China (Hong Kong). The function and indications of "San Zi Yang Qin Granules [Beijing Tongrentang]" are warming the lungs, resolving phlegm, and relieving qi stagnation and food difficulties. It is used for symptoms of phlegm block and qi stagnation, with symptoms including cough, asthma, excessive phlegm with chest fullness, decreased appetite, difficult digestion, white greasy tongue coating, and slippery pulse. As of the date of this announcement, the company has invested approximately HKD 800,000 (unaudited) in the research and development of "San Zi Yang Qin Granules [Beijing Tongrentang]," and this product has not yet been marketed for sale. With the acquisition of this certificate, the "San Zi Yang Qin Granules [Beijing Tongrentang]" produced by the company can be sold in Hong Kong, which will help diversify the company's product line and facilitate its market expansion. The acquisition of this certificate is not expected to have a significant impact on the company's production operations and financial performance. The sale of pharmaceutical products is susceptible to changes in the policy environment in Hong Kong, exchange rate fluctuations, market competition, and other factors.